Covid-19 Vaccine Pricing: Private Risk Or Public Funding?

PUBLISHED ON: April 30, 2021 | Duration: 4 min, 20 sec

  
loading..
"These companies have taken a risk to transfer technology and scale up these vaccines at their cost. SII took the technology from Oxford University who wanted a partner. We are prepared to give them clinical supplies," says Kiran Mazumdar Shaw, Executive Chairperson, Biocon, to NDTV.
ALSO WATCH
Puducherry Makes COVID-19 Vaccination Compulsory

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com